Mirador Capital Partners LP Horizon Therapeutics Public LTD CO Transaction History

Mirador Capital Partners LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 05, 2023	BUY	$98.98 - $115.74 $98 - $115	1 Added 0.04%	2,661 $307,000
Q1 2023 Apr 14, 2023	SELL	$107.32 - $113.5 $21,464 - $22,700	-200 Reduced 6.99%	2,660 $290,000
Q4 2022 Feb 09, 2023	BUY	$62.39 - $113.8 $178,435 - $325,468	2,860 New	2,860 $325,000
Q2 2022 Aug 05, 2022	SELL	$79.4 - $116.36 $3,970 - $5,818	-50 Reduced 1.7%	2,885 $230,000
Q1 2022 May 06, 2022	SELL	$86.42 - $109.81 $4,321 - $5,490	-50 Reduced 1.68%	2,935 $309,000
Q4 2021 Feb 02, 2022	SELL	$98.56 - $119.91 $56,869 - $69,188	-577 Reduced 16.2%	2,985 $322,000
Q3 2021 Nov 09, 2021	BUY	$91.91 - $110.37 $2,481 - $2,979	27 Added 0.76%	3,562 $390,000
Q2 2021 Jul 27, 2021	BUY	$86.24 - $95.92 $5,174 - $5,755	60 Added 1.73%	3,535 $331,000
Q1 2021 Apr 29, 2021	SELL	$71.83 - $95.48 $1,077 - $1,432	-15 Reduced 0.43%	3,475 $320,000
Q3 2020 Nov 12, 2020	SELL	$55.23 - $79.93 $6,075 - $8,792	-110 Reduced 3.06%	3,490 $271,000
Q2 2020 Aug 06, 2020	BUY	$30.2 - $56.98 $108,720 - $205,128	3,600 New	3,600 $200,000
Q1 2020 May 11, 2020	SELL	$24.87 - $38.56 $409,235 - $634,504	-16,455 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$25.43 - $36.67 $418,450 - $603,404	16,455 New	16,455 $596,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Mirador Capital Partners LP, based on Form 13F filings with the SEC.

Stay updated on Mirador Capital Partners LP with notifications on news.